Browsing Tag
Halozyme Therapeutics Inc.
2 posts
Halozyme Therapeutics stock rises 6.27% after beating Q1 expectations, raising 2025 outlook
Halozyme Therapeutics stock rose as Q1 earnings beat expectations and 2025 guidance improved. See how ENHANZE® drives royalty growth and future prospects.
ACADIA, Tonix, and D-Wave lead U.S. stock market gainers
Explore the top-performing U.S. stocks on May 16, 2025, as biotech, crypto, and tech names rally amid a trade truce and inflation worries. Read what drove gains.